Literature DB >> 22885171

Aggregation behavior of ibuprofen, cholic acid and dodecylphosphocholine micelles.

Priyanka Prakash1, Abdallah Sayyed-Ahmad, Yong Zhou, David E Volk, David G Gorenstein, Elizabeth Dial, Lenard M Lichtenberger, Alemayehu A Gorfe.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used to treat chronic pain and inflammation. However, prolonged use of NSAIDs has been known to result in Gastrointestinal (GI) ulceration/bleeding, with a bile-mediated mechanism underlying their toxicity to the lower gut. Bile acids (BAs) and phosphatidylcholines (PCs), the major components of bile, form mixed micelles to reduce the membrane disruptive actions of monomeric BAs and simple BA micelles. NSAIDs are suspected to alter the BA/PC balance in the bile, but the molecular interactions of NSAID-BA or NSAID-BA-PC remain undetermined. In this work, we used a series of all-atom molecular dynamics simulations of cholic acid (CA), ibuprofen (IBU) and dodecylphosphocholine (DPC) mixtures to study the spontaneous aggregation of CA and IBU as well as their adsorption on a DPC micelle. We found that the size of CA-IBU mixed micelles varies with their molar ratio in a non-linear manner, and that micelles of different sizes adopt similar shapes but differ in composition and internal interactions. These observations are supported by NMR chemical shift changes, NMR ROESY crosspeaks between IBU and CA, and dynamic light scattering experiments. Smaller CA-IBU aggregates were formed in the presence of a DPC micelle due to the segregation of CA and IBU away from each other by the DPC micelle. While the larger CA-IBU aggregates arising from higher IBU concentrations might be responsible for NSAID-induced intestinal toxicity, the absence of larger CA-IBU aggregates in the presence of DPC micelles may explain the observed attenuation of NSAID toxicity by PCs.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885171      PMCID: PMC3478136          DOI: 10.1016/j.bbamem.2012.07.029

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  The stereoselective uptake of ibuprofen enantiomers into adipose tissue.

Authors:  K Williams; R Day; R Knihinicki; A Duffield
Journal:  Biochem Pharmacol       Date:  1986-10-01       Impact factor: 5.858

2.  Enterohepatic circulation of indomethacin and its role in intestinal irritation.

Authors:  D E Duggan; K F Hooke; R M Noll; K C Kwan
Journal:  Biochem Pharmacol       Date:  1975-10-01       Impact factor: 5.858

3.  Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects.

Authors:  B S Anand; J J Romero; S K Sanduja; L M Lichtenberger
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

4.  Molecular dynamics simulations of mixed micelles modeling human bile.

Authors:  S J Marrink; A E Mark
Journal:  Biochemistry       Date:  2002-04-30       Impact factor: 3.162

5.  Structure and dynamics of cholic acid and dodecylphosphocholine-cholic acid aggregates.

Authors:  Abdallah Sayyed-Ahmad; Lenard M Lichtenberger; Alemayehu A Gorfe
Journal:  Langmuir       Date:  2010-08-17       Impact factor: 3.882

6.  CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Authors:  K Vanommeslaeghe; E Hatcher; C Acharya; S Kundu; S Zhong; J Shim; E Darian; O Guvench; P Lopes; I Vorobyov; A D Mackerell
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

7.  Quasielastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions.

Authors:  N A Mazer; G B Benedek; M C Carey
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

8.  Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.

Authors:  F L Lanza; U K Marathi; B S Anand; L M Lichtenberger
Journal:  Aliment Pharmacol Ther       Date:  2008-06-11       Impact factor: 8.171

9.  Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes.

Authors:  Elizabeth J Dial; Suzan H M Rooijakkers; Rebecca L Darling; Jim J Romero; Lenard M Lichtenberger
Journal:  J Gastroenterol Hepatol       Date:  2007-09-12       Impact factor: 4.029

10.  Mechanisms of acute and chronic intestinal inflammation induced by indomethacin.

Authors:  T Yamada; E Deitch; R D Specian; M A Perry; R B Sartor; M B Grisham
Journal:  Inflammation       Date:  1993-12       Impact factor: 4.092

View more
  5 in total

1.  In vitro evidence that phosphatidylcholine protects against indomethacin/bile acid-induced injury to cells.

Authors:  Elizabeth J Dial; Paul A Dawson; Lenard M Lichtenberger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

2.  Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80.

Authors:  Meysam Mobasheri; Hossein Attar; Seyed Mehdi Rezayat Sorkhabadi; Ali Khamesipour; Mahmoud Reza Jaafari
Journal:  Molecules       Date:  2015-12-24       Impact factor: 4.411

3.  pMD-Membrane: A Method for Ligand Binding Site Identification in Membrane-Bound Proteins.

Authors:  Priyanka Prakash; Abdallah Sayyed-Ahmad; Alemayehu A Gorfe
Journal:  PLoS Comput Biol       Date:  2015-10-27       Impact factor: 4.475

4.  Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.

Authors:  Zhou Zhou; Claire Dunn; Ibrahim Khadra; Clive G Wilson; Gavin W Halbert
Journal:  Eur J Pharm Sci       Date:  2016-12-07       Impact factor: 4.384

Review 5.  RAS Nanoclusters Selectively Sort Distinct Lipid Headgroups and Acyl Chains.

Authors:  Yong Zhou; Alemayehu A Gorfe; John F Hancock
Journal:  Front Mol Biosci       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.